Skip to content
"There are a multiplicity of medical trials"

Invited on France 24, Jean Mariani, physician and professor emeritus at Sorbonne College, gave an replace on Thursday on the therapeutic trials in progress and the remedies at present used to deal with Covid-19.

As France enters its 24th day of confinement on Thursday, Jean Mariani, physician and professor on the Sorbonne medical college, reviewed Thursday on France 24 the assorted therapeutic trials and coverings used to fight Covid-19 .

"There are a multiplicity of medical trials which all have completely different targets", he summarizes, earlier than recalling {that a} vaccine, "higher resolution" towards the eradication of Covid-19 in line with him, is not going to be out there "earlier than a number of months, a 12 months or perhaps a 12 months and a half".

>> Learn additionally: "Coronavirus: the pharmaceutical trade is dedicated to offering a vaccine inside 12 to 18 months"

Pending the sale of a vaccine, there are medication known as antivirals, comparable to chloroquine, which can assist deal with sufferers with Covid-19. These antivirals "are the topic of a mixed therapeutic trial known as Discovery in Europe", feedback Jean Mariani.

The director of the Institute of Longevity additionally quotes "the usage of antibodies in topics who’ve been contaminated". That is "plasma remedy", which goals to inject the antibodies of a former affected person into the physique of an individual affected by Covid-19.

One other resolution: "symptomatic remedy", in line with Jean Mariani. Primarily supposed to deal with extreme types of the illness, it consists in attempting to "make sufferers survive so long as potential in intensive care, generally with a really tough passage by remaining in incubation and synthetic respiration", he explains.

"No actual remedy"

In line with the physician, analysis is underway to enhance any such remedy. "To extend survival, there may be the potential for performing utilizing knowledge from analysis on the biology of growing old," says Jean Mariani. The purpose is thus to "discover a class of medication to extend the affected person's resilience", which the professor defines as "the flexibility of a person to withstand aggression".

>> Learn additionally: "Dangers of contagion, plasma, contaminated animals: the newest work on the coronavirus"

Experiments are additionally underway on serological assessments. The target is to "discover the antibodies which testify that the person has been contaminated and that he’s protected", in line with Jean Mariani. "The issue is that we’d like time as a result of even when antibody detection assessments are produced, it’s important to examine their reliability."

"Presently, this reliability isn’t totally established (…). We can’t afford to not have, specifically throughout the framework of a large screening, extraordinarily dependable assessments", factors out the specialist. He takes the instance of Spain "which ordered a number of hundred thousand assessments in China which it was pressured to throw away as a result of they weren’t dependable".

Earlier than treating the sufferers, Jean Mariani reminds us that it’s mandatory "to detect contaminated topics, separate them from wholesome topics after which probably deal with them". Nevertheless, in line with him, "at present, there isn’t any actual remedy", which explains why confinement was chosen as an "inevitable" interim resolution.

Jean Mariani then insists on a deadly error within the administration of the disaster: precipitation. "This pandemic goes very quick however this urgency mustn’t make us neglect that we should exhibit by medication the effectiveness of a sure variety of remedies."

Comments